Pharmacological agents targeting drug-tolerant persister cells in cancer
Current cancer therapy can be effective, but the development of drug resistant disease is the usual outcome. These drugs can eliminate most of the tumor burden but often fail to eliminate the rare, "Drug Tolerant Persister" (DTP) cell subpopulations in residual tumors, which can be referre...
Saved in:
Main Authors: | Yu-Chi Chen (Author), Krishne Gowda (Author), Shantu Amin (Author), Todd D. Schell (Author), Arun K. Sharma (Author), Gavin P. Robertson (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of a novel Bruton's tyrosine kinase inhibitor that exerts anti-cancer activities potentiates response of chemotherapeutic agents in multiple myeloma stem cell-like cells
by: Weam Othman Elbezanti, et al.
Published: (2022) -
Tolerance and Persister Formation in Oral Streptococci
by: Stephanie Suppiger, et al.
Published: (2020) -
Incidentally detected clear cell renal cell carcinoma with rhabdoid differentiation
by: Venkatesh Krishnamoorthy, et al.
Published: (2016) -
Mucinous eccrine carcinoma of the eyelid: re-emphasizing the need for awareness of rare lesions
by: Kiran Krishne Gowda, et al.
Published: (2014) -
A pharmacologic basis for HIV persistence
by: C. Fletcher
Published: (2015)